Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial - Mir, O; Brodowicz, T; Italiano, A (Lancet Oncol, 2016)